Cogent Biosciences COGT
NASDAQ COGT
$32.02 +0.36 (+1.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Other financing activities (2025)

Updated

Cogent Biosciences' Other financing activities was $46.59 million in Q4 2025.

Analysis

Cogent Biosciences (COGT) Other financing activities (2025) Analysis & Trends

For FY2025, Other financing activities at Cogent Biosciences came in at $48.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cogent Biosciences 5.49 Bn 5.49 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46.59 Mn
Sep 30, 2025 235,000.00
API Access

Cogent Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=COGT&period=max&api_key=YOUR_API_KEY